Claveria-Cabello, A., Colyn, L., Uriarte, I., Latasa, M. U., Arechederra, M., Herranz, J. M., . . . Fernandez-Barrena, M. G. (2020). Dual Pharmacological Targeting of HDACs and PDE5 Inhibits Liver Disease Progression in a Mouse Model of Biliary Inflammation and Fibrosis. Cancers (Basel).
Chicago ZitierstilClaveria-Cabello, Alex, et al. "Dual Pharmacological Targeting of HDACs and PDE5 Inhibits Liver Disease Progression in a Mouse Model of Biliary Inflammation and Fibrosis." Cancers (Basel) 2020.
MLA ZitierstilClaveria-Cabello, Alex, et al. "Dual Pharmacological Targeting of HDACs and PDE5 Inhibits Liver Disease Progression in a Mouse Model of Biliary Inflammation and Fibrosis." Cancers (Basel) 2020.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.